Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Bussel

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 10, 2019
Peri- and Postpartum Management of Patients With Factor XI DeficiencyGloria F Gerber, Kelsey A Klute, John Chapin, et al.
Platelets|November 8, 2016
Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP)Sif Gudbrandsdottir, Waleed Ghanima, Claus H Nielsen, et al.
Platelets|March 5, 2016
Hospitalizations in pediatric patients with immune thrombocytopenia in the United StatesMichael D Tarantino, Mark Danese, Robert J Klaassen, et al.
British Journal of Haematology|August 16, 2002
High P-glycoprotein-mediated export observed in patients with a history of idiopathic thrombocytopenic purpuraAdam S Levy, Susanna Cunningham-Rundles, BethAnne Mazza, et al.
Circulation|January 12, 2011
Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agentsJorge Magallon, Jianchun Chen, Leroy Rabbani, et al.
Seminars in Hematology|December 15, 2019
Mechanisms and therapeutic prospects of thrombopoietin receptor agonistsJames Bussel, Austin Kulasekararaj, Nichola Cooper, et al.
American Journal of Hematology|June 30, 2004
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodiesLouis M Aledort, Catherine P M Hayward, Mon-Gy Chen, et al.
Blood|August 24, 2012
CD16+ monocytes control T-cell subset development in immune thrombocytopeniaHui Zhong, Weili Bao, Xiaojuan Li, et al.
American Journal of Hematology|September 5, 2009
Repeated courses of rituximab in chronic ITP: Three different regimensAisha Hasan, Marc Michel, Vivek Patel, et al.
American Journal of Perinatology|November 25, 2025
Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune ThrombocytopeniaJames Bussel, Barbara Stegmann, Pamela Baker, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 10, 2019
Peri- and Postpartum Management of Patients With Factor XI DeficiencyGloria F Gerber, Kelsey A Klute, John Chapin, et al.
Platelets|November 8, 2016
Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP)Sif Gudbrandsdottir, Waleed Ghanima, Claus H Nielsen, et al.
Platelets|March 5, 2016
Hospitalizations in pediatric patients with immune thrombocytopenia in the United StatesMichael D Tarantino, Mark Danese, Robert J Klaassen, et al.
British Journal of Haematology|August 16, 2002
High P-glycoprotein-mediated export observed in patients with a history of idiopathic thrombocytopenic purpuraAdam S Levy, Susanna Cunningham-Rundles, BethAnne Mazza, et al.
Circulation|January 12, 2011
Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agentsJorge Magallon, Jianchun Chen, Leroy Rabbani, et al.
Seminars in Hematology|December 15, 2019
Mechanisms and therapeutic prospects of thrombopoietin receptor agonistsJames Bussel, Austin Kulasekararaj, Nichola Cooper, et al.
American Journal of Hematology|June 30, 2004
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodiesLouis M Aledort, Catherine P M Hayward, Mon-Gy Chen, et al.
Blood|August 24, 2012
CD16+ monocytes control T-cell subset development in immune thrombocytopeniaHui Zhong, Weili Bao, Xiaojuan Li, et al.
American Journal of Hematology|September 5, 2009
Repeated courses of rituximab in chronic ITP: Three different regimensAisha Hasan, Marc Michel, Vivek Patel, et al.
American Journal of Perinatology|November 25, 2025
Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune ThrombocytopeniaJames Bussel, Barbara Stegmann, Pamela Baker, et al.
Pageof 6